semaglutide vs tirzepatide microdosing GLP-1s: A Doctor's Guide to Gentle, Effective Metabolic Reset: Shamsah Amersi, MD: OB-GYNs People Are Microdosing Weight-Loss Drugs

"Eating a variety of fruit and vegetables, you get your potassium and fiber," she says

Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass

Plausible signaling is a starting point for investigation, not a substitute for human safety and efficacy data

What side effects can naltrexone/bupropion cause

Semaglutide, a novel GLP-1 receptor agonist, was investigated in a recently completed phase 2 placebo-controlled trial comparing the efficacy and safety of different doses in 320 NASH patients and the results are awaited (NCT02970942)